CAS 60548-08-5
:4-Quinazolinamine, 6,7-diméthoxy-2-(1-pipérazinyl)-, dichlorhydrate
Terazosin Related Compound A (6,7-Dimethoxy-2-(piperazin-1-yl)quinazolin-4-amine dihydrochloride)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C14H19N5O2·2HClCouleur et forme :White PowderMasse moléculaire :289.153876,7-Dimethoxy-2-(piperazin-1-yl)quinazolin-4-amine dihydrochloride
CAS :6,7-Dimethoxy-2-(piperazin-1-yl)quinazolin-4-amine dihydrochlorideDegré de pureté :97%Masse moléculaire :362.26g/molN-Des((tetrahydrofuran-2-yl)methanone)) Terazosin Dihydrochloride
CAS :Produit contrôléApplications N-Des((tetrahydrofuran-2-yl)methanone)) Terazosin Dihydrochloride is a related compound to Terazosin (T105000), a α-1-adrenergic blocker related to Prazosin (P702325).
References Patterson, S.E., et al.: J. Chromatog., 311, 206 (1984), Fort, F.L., et al.: Drug Chem. Toxicol., 7, 435 (1984), Lepor, H., et al.: J. Urol., 148, 1467 (1992),Formule :C14H19N5O2HClCouleur et forme :NeatMasse moléculaire :362.256,7-Dimethoxy-2-(piperazin-1-yl)quinazolin-4-amine dihydrochloride
CAS :6,7-Dimethoxy-2-(piperazin-1-yl)quinazolin-4-amine dihydrochloride (DMPQ) is a piperazine derivative that is a potent and selective inhibitor of phosphodiesterase type 5 (PDE5). This drug has been shown to be useful in the treatment of the symptoms of benign prostatic hyperplasia. DMPQ inhibits the hydrolysis of cyclic adenosine monophosphate (cAMP), which leads to an increase in intracellular levels of cAMP. This drug also exhibits antihypertensive effects, as it inhibits the activity of nitric oxide synthase.
Formule :C14H21Cl2N5O2Degré de pureté :Min. 95%Masse moléculaire :362.3 g/mol





